Cargando…
Being as Normal as Possible: How Young People Ages 16–25 Years Evaluate the Risks and Benefits of Treatment for Inflammatory Arthritis
OBJECTIVE: To explore how young people (ages 16–25 years) with inflammatory arthritis evaluate the risks and benefits of treatment, particularly treatment with biologic therapies. METHODS: This qualitative study involved in‐depth interviews (n = 44) with young people, trusted others (e.g., parents),...
Autores principales: | Hart, Ruth I., McDonagh, Janet E., Thompson, Ben, Foster, Helen E., Kay, Lesley, Myers, Andrea, Rapley, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042182/ https://www.ncbi.nlm.nih.gov/pubmed/27040737 http://dx.doi.org/10.1002/acr.22832 |
Ejemplares similares
-
Enhancing Patient Understanding of Medication Risks and Benefits
por: Blalock, Susan J., et al.
Publicado: (2021) -
Possibilities for personalised medicine in rheumatoid arthritis: hype or hope
por: Heutz, Judith, et al.
Publicado: (2021) -
After 25 years of drug development, do we know JAK?
por: Mortezavi, Mahta, et al.
Publicado: (2022) -
Management of Fatigue in Rheumatoid Arthritis
por: Pope, Janet E
Publicado: (2020) -
Physician global assessments for disease activity in rheumatoid arthritis are all over the map!
por: Turk, Matthew, et al.
Publicado: (2018)